Yonghe Medical Group Co Ltd
HKEX:2279
Balance Sheet
Balance Sheet Decomposition
Yonghe Medical Group Co Ltd
Yonghe Medical Group Co Ltd
Balance Sheet
Yonghe Medical Group Co Ltd
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Investments |
68
|
90
|
293
|
1 566
|
977
|
603
|
|
| Total Receivables |
36
|
43
|
66
|
78
|
83
|
97
|
|
| Accounts Receivables |
10
|
6
|
10
|
13
|
7
|
10
|
|
| Other Receivables |
26
|
37
|
55
|
65
|
76
|
86
|
|
| Inventory |
14
|
14
|
27
|
53
|
88
|
76
|
|
| Other Current Assets |
34
|
31
|
52
|
51
|
41
|
33
|
|
| Total Current Assets |
153
|
178
|
438
|
1 749
|
1 189
|
809
|
|
| PP&E Net |
567
|
726
|
1 120
|
1 375
|
1 632
|
1 490
|
|
| PP&E Gross |
567
|
726
|
1 120
|
1 375
|
1 632
|
1 490
|
|
| Accumulated Depreciation |
105
|
221
|
334
|
502
|
712
|
934
|
|
| Intangible Assets |
1
|
3
|
4
|
16
|
15
|
25
|
|
| Goodwill |
0
|
0
|
0
|
25
|
25
|
10
|
|
| Other Long-Term Assets |
13
|
23
|
33
|
34
|
70
|
110
|
|
| Other Assets |
0
|
0
|
0
|
25
|
25
|
10
|
|
| Total Assets |
734
N/A
|
931
+27%
|
1 594
+71%
|
3 199
+101%
|
2 930
-8%
|
2 445
-17%
|
|
| Liabilities | |||||||
| Accounts Payable |
17
|
23
|
45
|
36
|
44
|
79
|
|
| Accrued Liabilities |
36
|
40
|
79
|
147
|
82
|
101
|
|
| Short-Term Debt |
0
|
45
|
26
|
74
|
0
|
153
|
|
| Current Portion of Long-Term Debt |
75
|
97
|
147
|
185
|
191
|
170
|
|
| Other Current Liabilities |
78
|
76
|
209
|
296
|
182
|
220
|
|
| Total Current Liabilities |
205
|
281
|
505
|
738
|
499
|
723
|
|
| Long-Term Debt |
325
|
411
|
683
|
762
|
845
|
773
|
|
| Deferred Income Tax |
1
|
0
|
0
|
1
|
2
|
7
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
531
N/A
|
692
+30%
|
1 188
+72%
|
1 501
+26%
|
1 345
-10%
|
1 502
+12%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
203
|
239
|
406
|
458
|
253
|
390
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1 240
|
1 332
|
1 332
|
|
| Total Equity |
203
N/A
|
239
+18%
|
406
+70%
|
1 698
+318%
|
1 585
-7%
|
943
-41%
|
|
| Total Liabilities & Equity |
734
N/A
|
931
+27%
|
1 594
+71%
|
3 199
+101%
|
2 930
-8%
|
2 445
-17%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
520
|
520
|
520
|
520
|
527
|
527
|
|